(Q34831241)

4 August 2017

1 reference

title

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses (English)

1 reference

4 August 2017

0 references

0 references

2

Rudolph E Tanzi

1 reference

4 August 2017

1

Lars Bertram

1 reference

PubMed ID

18802446

4 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Nature Reviews Neuroscience

4 August 2017

1 reference

4 August 2017

9

1 reference

4 August 2017

768-778

1 reference

4 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn2494

4 August 2017

0 references

cites work

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

1 reference

The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study

31 March 2020

1 reference

The number of trait loci in late-onset Alzheimer disease

31 March 2020

1 reference

Role of Genes and Environments for Explaining Alzheimer Disease

31 March 2020

1 reference

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

31 March 2020

1 reference

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

31 March 2020

1 reference

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

31 March 2020

1 reference

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

31 March 2020

1 reference

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

31 March 2020

1 reference

Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants

31 March 2020

1 reference

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

31 March 2020

1 reference

Alzheimer's disease and HLA.

31 March 2020

1 reference

31 March 2020

1 reference

Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme Gene

31 March 2020

1 reference

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity

31 March 2020

1 reference

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor

31 March 2020

1 reference

Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.

31 March 2020

1 reference

Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease

31 March 2020

1 reference

The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential

31 March 2020

1 reference

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

31 March 2020

1 reference

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia

31 March 2020

1 reference

Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy

31 March 2020

1 reference

Biochemical markers of Alzheimer's disease: wish and reality

31 March 2020

1 reference

Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease.

31 March 2020

1 reference

Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein.

31 March 2020

1 reference

Alzheimer's disease: the cholesterol connection

31 March 2020

1 reference

Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.

31 March 2020

1 reference

Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease

31 March 2020

1 reference

The role of nicotinic acetylcholine receptors in Alzheimer's disease

31 March 2020

1 reference

31 March 2020

1 reference

Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors

31 March 2020

1 reference

beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells

31 March 2020

1 reference

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

31 March 2020

1 reference

The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy

31 March 2020

1 reference

The role of the nicotinic acetylcholine receptors in sleep-related epilepsy

31 March 2020

1 reference

Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia

31 March 2020

1 reference

Expression of cystatin C in rat, monkey and human brains

31 March 2020

1 reference

SstII polymorphic sites in the promoter region of the human cystatin C gene

31 March 2020

1 reference

Alzheimer disease-associated cystatin C variant undergoes impaired secretion.

31 March 2020

1 reference

Unexpected intracellular localization of the AMD-associated cystatin C variant.

31 March 2020

1 reference

Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation

31 March 2020

1 reference

Cystatin C modulates cerebral beta-amyloidosis

31 March 2020

1 reference

Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B.

31 March 2020

1 reference

The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models

31 March 2020

1 reference

31 March 2020

1 reference

The multiple function of Grb2 associated binder (Gab) adaptor/scaffolding protein in immune cell signaling.

31 March 2020

1 reference

Association study of the GAB2 gene with the risk of developing Alzheimer's disease.

31 March 2020

1 reference

Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases

31 March 2020

1 reference

Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling

31 March 2020

1 reference

The laminopathies: a clinical review

31 March 2020

1 reference

Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids.

31 March 2020

1 reference

Human laminopathies: nuclei gone genetically awry

31 March 2020

1 reference

High-resolution whole-genome association study of Parkinson disease.

31 March 2020

1 reference

Family-based association between Alzheimer's disease and variants in UBQLN1

31 March 2020

1 reference

The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments

31 March 2020

1 reference

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

31 March 2020

1 reference

Whole-genome patterns of common DNA variation in three human populations

31 March 2020

1 reference

A common inversion under selection in Europeans

31 March 2020

1 reference

Untangling the tau gene association with neurodegenerative disorders.

31 March 2020

1 reference

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

31 March 2020

1 reference

High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy

31 March 2020

1 reference

Tau haplotypes regulate transcription and are associated with Parkinson's disease.

31 March 2020

1 reference

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition

31 March 2020

1 reference

Sporadic and familial CJD: classification and characterisation.

31 March 2020

1 reference

Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease

31 March 2020

1 reference

Prion protein (PrPc) promotes beta-amyloid plaque formation.

31 March 2020

1 reference

Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation

31 March 2020

1 reference

The presence of valine at residue 129 in human prion protein accelerates amyloid formation.

31 March 2020

1 reference

Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member.

31 March 2020

1 reference

LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro

31 March 2020

1 reference

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein

31 March 2020

1 reference

Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11.

31 March 2020

1 reference

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

31 March 2020

1 reference

The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments

31 March 2020

1 reference

Loss of apolipoprotein E receptor LR11 in Alzheimer disease

31 March 2020

1 reference

Neuronal LR11/sorLA expression is reduced in mild cognitive impairment

31 March 2020

1 reference

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

31 March 2020

1 reference

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

31 March 2020

1 reference

Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease.

31 March 2020

1 reference

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

31 March 2020

1 reference

The effect of transferrin polymorphisms on iron metabolism

31 March 2020

1 reference

The C2 variant of human serum transferrin retains the iron binding properties of the native protein.

31 March 2020

1 reference

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

31 March 2020

1 reference

Alzheimer's disease in Finnish twins.

31 March 2020

1 reference

Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel

31 March 2020

1 reference

Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins

31 March 2020

1 reference

How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD.

31 March 2020

1 reference

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

31 March 2020

1 reference

Genome-wide significance for dense SNP and resequencing data

31 March 2020

1 reference

Meta-analysis in clinical trials

31 March 2020

1 reference

Assessment of cumulative evidence on genetic associations: interim guidelines

31 March 2020

1 reference

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

31 March 2020

1 reference

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

31 March 2020

1 reference

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

31 March 2020

1 reference

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

31 March 2020

1 reference

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

31 March 2020

1 reference

Of replications and refutations: the status of Alzheimer's disease genetic research

31 March 2020

1 reference

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

31 March 2020

1 reference

A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease.

31 March 2020

1 reference

Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.

31 March 2020

1 reference

Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.

31 March 2020

1 reference

A polymorphism in the tau gene associated with risk for Alzheimer's disease.

31 March 2020

1 reference

Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?

31 March 2020

1 reference

PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

31 March 2020

1 reference

Association of novel and established polymorphisms in neuronal nicotinic acetylcholine receptors with sporadic Alzheimer's disease

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased frequency of the transferrin C2 subtype in Alzheimer's disease

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRN2494

1 reference

PubMed ID

18802446

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

18802446